Medical Analysis

Comprehensive Medical Analysis of Phencyclidine (PCP), Pharmacological Action, Clinical Toxicology, Diagnostic Testing, and Regulatory Landscapes

Introduction- PCP, Alternative Nomenclature, and Chemical Origins

Phencyclidine, commonly known as PCP and associated with street names and slang terms such as Angel Dust, Embalming fluid, Hog, Killer Weed, Love boat, Ozone, Peace pill, Rocket fuel, Super grass, and Wack, represents a synthetic dissociative drug originally developed as an intravenous anesthetic [1, 2]. Marijuana or tobacco cigarettes that are dipped in PCP are frequently referred to as illy, wet, or fry [3]. PCP is an infamous hallucinogenic sought after for its distinct ability to induce the illusion of euphoria, omnipotence, superhuman strength, and heightened social and sexual prowess [3, 4].

Mode of Action of PCP, Receptor Dynamics, and Neuropharmacological Pathways

Phencyclidine functions primarily as an NMDA receptor antagonist, which actively blocks the normal physiological activity of the N-methyl-D-aspartate receptor [15, 17]. The N-methyl-D-aspartate receptor represents a specific type of ionotropic receptor that is localized on the dendrites of neurons and is responsible for receiving electrochemical signals in the form of neurotransmitters [17, 18]. By blocking these crucial receptor sites, PCP disrupts normal glutamatergic neurotransmission, leading to profound alterations in sensory processing, cognitive function, and behavioral regulation within the central nervous system [15, 17].

Indications – PCP, Clinical, Forensic, and Occupational Testing Contexts

Diagnostic and toxicological evaluation of PCP is indicated across a diverse range of legal, occupational, and medical scenarios [8]. These indications encompass:

• Forensic or Legal Purpose: To determine whether an individual has used or possessed substances such as LSD as part of ongoing criminal proceedings [8, 12].

• Random Workplace Testing: Utilized routinely as part of comprehensive employment screening programs [8].

• Clinical Assessment: Conducted when acute or chronic psychedelic and dissociative exposure is clinically suspected [3, 6].

• Sports and Athletes: Enforced rigorously because the use of PCP is strictly illegal in competitive sports [8].

• Post-Accident Testing: Performed following critical workplace or vehicular accidents [8, 12].

• Pre-Employment Testing: Implemented during initial hiring and candidate vetting processes [8].

• Abstinence Monitoring: Applied to monitor patient abstinence and adherence to substance abuse treatment protocols [8].

• Follow-Up Testing: Utilized for ongoing follow-up evaluation concerning drug abuse or acute toxicity [3, 8].

• Probation, Parole & Social Services: Mandated strictly in accordance with official court orders [8].

PCP – Clinical Signs, Psychological Symptoms, and Behavioral Manifestations

The clinical presentation of PCP toxicity involves a complex spectrum of physiological, psychological, and behavioral disturbances that require careful medical evaluation [3, 6].

Physical manifestations include increased blood pressure, tachycardia, severe insomnia, abnormally small or dilated pupils, flushed skin, and profound loss of coordination [3, 5, 6].

Psychological manifestations encompass delusions, paranoia involving irrational suspicion or distrust, acute agitation, hallucinations, altered perception of reality, distorted sensory perception, emotional instability, psychosis, and severe depression [3, 5, 13].

Behavioral manifestations feature memory loss, intense physiological and psychological craving, extreme mood swings, social withdrawal, confusion, disorientation, impulsivity, and bizarre or violent behavior [3, 4, 13].

METHODS OF ESTIMATION and Laboratory Protocols

Analytical confirmation of PCP and its metabolites relies upon an extensive array of advanced laboratory methodologies:

• Liquid Chromatography-Tandem Mass Spectrometry [9, 10].

• Gas Chromatography-Mass Spectrometry [9, 10].

• HPLC-MS (HPLE coupled with Mass Spectrophotometry) [10, 11].

• CE-MS (Capillary Electrophoresis coupled with Mass Spectrophotometry) [11].

• Paper chromatography and thin-layer chromatography [11].

• Spectrophotofluorometric methods [11].

• Immunoassay (IA) [8].

• Lateral flow chromatographic immunoassay [8].

• Enzyme-linked immunosorbent assay (ELISA) methods [8].

• Ultra-violet spectrophotometry and infrared (IR) spectrophotometry [11].

BEFORE SAMPLE COLLECTION

No special preparation is required for the test [9].

Samples Needed for PCP Testing

PCP Cut Off Value in Various Biological Samples

Regulatory Situation of PCP – Clinical Research and Global Status

LIMITATIONS of Diagnostic Assays

Gas chromatography/mass spectrometry (GC/MS) serves as the preferred confirmatory method [9, 10]. Technical or procedural errors, as well as other interfering substances present within the urine specimen, may cause erroneous results [8, 9]. Adulterants, such as bleach and/or alum, added to urine specimens may produce erroneous results regardless of the analytical method utilized [8, 9]. Instances of specimen dilution or substitution may produce false negative results [8, 9]. A positive analytical result indicates the presence of the drug or its metabolites but does not indicate the exact level of intoxication, route of administration, or specific concentration in urine [8, 9]. High testing costs and limited resource availability mean that facilities cannot always provide testing everywhere [8, 9]. A lack of specialized expertization may limit its routine clinical use [8, 9]. The rate of metabolism and excretion of the drug varies significantly from person to person, which may affect its detection window and subsequent clinical interpretation [9, 10]. A negative result may not necessarily indicate drug-free urine, as negative results can be obtained when the drug is present but falls below the established cut-off level of the test [8, 9]. Interpretation of results must take into account that urine concentrations can vary extensively with fluid intake and other biological variables [8, 9]. Furthermore, immunoassays that produce a single aggregate result in the presence of a drug and its metabolites cannot fully quantitate the individual concentration of separate components [8, 9].

Refer Legal & Police Prospective Aspects

For further legal documentation and investigative protocols, refer to the presentation titled: Drugs – Sample Submission for Legal Side & Police Department [8, 12]. Trusted insights are curated by Dr. Dipak Ladda [8, 12].

For Non-Medicos

Understanding PCP and Its Effects

Phencyclidine, commonly known as PCP or Angel Dust, is a powerful synthetic drug that interferes with normal brain signaling [1, 2]. It was originally created as an anesthetic but was discontinued for human use due to severe side effects [1, 2]. People who use PCP often experience extreme behavioral changes, hallucinations, a feeling of immense strength, severe confusion, and a complete break from reality [3, 4].

Testing, Medical Safety, and Legal Regulations

Healthcare providers, employers, and law enforcement agencies use urine, blood, hair, saliva, or tissue samples to test for PCP exposure [8, 9]. Because PCP causes dangerous psychological reactions, violent behavior, and loss of body control, it is strictly illegal for recreational use and banned in competitive sports [3, 8]. While it has no approved medical use today, researchers occasionally study it in laboratory settings to better understand brain conditions like schizophrenia [7, 15, 16].

References:

1. Burns RS, Lerner SE, Corrado R, James SH, Schnoll SH. Phencyclidine—states of acute intoxication and fatalities. West J Med. 1975;123(5):345-349.

2. Burns RS, Lerner SE. Perspectives: acute phencyclidine intoxication. Clin Toxicol. 1976;9(4):477-501.

3. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med. 1981;10(6):290-297.

4. Bey T, Patel A. Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med. 2007;8(1):9-14.

5. Dominici P, Kopec K, Manur R, Khalid A, Damiron K, Rowden A. Phencyclidine intoxication case series study. J Med Toxicol. 2015;11(3):321-325.

6. Journey JD, Bentley TP. Phencyclidine Toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.

7. National Institute on Drug Abuse (NIDA). Research Report Series: Hallucinogens and Dissociative Drugs. Bethesda (MD): U.S. Department of Health and Human Services; 2020.

8. Substance Abuse and Mental Health Services Administration (SAMHSA). Mandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist. 2017;82(13):7920-7972.

9. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 12th ed. Seal Beach (CA): Biomedical Publications; 2020.

10. Levine B. Principles of Forensic Toxicology. 5th ed. Washington (DC): American Academy of Forensic Sciences; 2020.

11. Moffat AC, Osselton MD, Widdop B, Watts J, eds. Clarke’s Analysis of Drugs and Poisons. 4th ed. London: Pharmaceutical Press; 2011.

12. Logan BK, Goldberger BA, Macdonald RL. Recent advances in the forensic toxicology of drug-facilitated sexual assault and drug testing. J Forensic Sci. 2019;64(S1):S12-S22.

13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. Washington (DC): American Psychiatric Association; 2022.

14. World Health Organization. The ICD-11 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 2022.

15. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20(3):201-225.

16. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148(10):1301-1308.

17. Olney JW, Farber NB. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools. Neuropsychopharmacology. 1995;13(4):335-345.

18. Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. 8th ed. Oxford: Oxford University Press; 2003.

FAQ’s:

• What is PCP?
  PCP is a synthetic dissociative drug originally developed as an intravenous anesthetic.

• How does PCP work?
  PCP acts primarily as an NMDA receptor antagonist, blocking normal glutamatergic neurotransmission.

• What are common street names?
  Common street names include Angel Dust, Embalming fluid, Hog, and Killer Weed.

• Why is PCP tested?
  PCP testing is indicated for forensic, workplace, clinical, sports, and probation monitoring purposes.

• What are the physical symptoms?
  Physical symptoms include increased blood pressure, tachycardia, severe insomnia, and poor coordination.

• What psychological effects occur?
  Effects include delusions, paranoia, acute agitation, hallucinations, psychosis, and severe depression.

• What samples are needed?
  Samples include urine, blood, hair, saliva, and tissue or organs.

• What is the urine cutoff?
  The urine cutoff value to label results positive is greater than 25 ng/ml.

• Are there approved medical uses?
  PCP has no approved medical use in the USA or Europe today.

• Can adulterants alter test results?
  Yes, adulterants like bleach or alum can produce erroneous test results.